Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

The U.S. COVID-19 vaccine rollout continues to lag but is accelerating

By Brian Buntz | January 25, 2021

Vaccine

Photo by Thirdman from Pexels

Some 20.5 million doses of COVID-19 vaccines have been administered as of Jan. 23 — roughly in line with the CDC’s end-of-2020 goal. 

The pace of vaccination as of the morning of Jan. 21 was roughly 1 million, about four-fifths involving initial doses of the two-dose vaccine. The daily pace ticked up to 1.4 million on Jan. 24 with 1.1 million of those initial doses. 

For the sake of comparison, COVID-19 tests were 1.9 million on the same day. 

At the current vaccination rate, vaccinating the majority of Americans could occur by January 2022, according to an analysis from The Wall Street Journal.  

It is likely, however, that the pace will continue to quicken as a growing number of organizations become involved in administering shots. Johnson & Johnson’s (NYSE:JNJ) could also file for emergency use authorization for a single-dose vaccine as early as February. 

President Biden has also promised that the U.S. would hit a pace of 1.5 million doses administered per day.

At present, UBS estimates that 4.6% of the U.S. population has received at least one dose of the two-dose vaccines from Moderna (NSDQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NSDQ:BNTX). 

According to official records, some 25 million Americans have been infected with COVID-19. 

In general, anywhere from 50% to 90% of a population needs immunity — either from natural infections or vaccines — to achieve herd immunity. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards